Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute of Applied Clinical Science and Primary Care and Health Sciences, Keele University, Keele, United Kingdom.
Research Institute for Primary Care and Health Sciences, Keele University, Keele, United Kingdom; Midlands Partnership NHS Foundation Trust, Staffordshire, United Kingdom.
Can J Cardiol. 2019 Jul;35(7):821-830. doi: 10.1016/j.cjca.2019.04.021. Epub 2019 May 2.
Severe mental illness (SMI) is associated with increased cardiovascular mortality. We sought to examine the prevalence, clinical outcomes, and management strategy of patients with SMI presenting with acute myocardial infarction (AMI).
All AMI hospitalizations from the National Inpatient Sample were included, stratified by mental health status into 5 groups: no SMI, schizophrenia, other non-organic psychoses (ONOP), bipolar disorder, and major depression. Regression analyses were performed to assess the association (adjusted odds ratios [ORs], P ≤ 0.001 for all outcomes) between SMI subtypes and clinical outcomes.
Of 6,968,777 AMI hospitalizations between 2004 and 2014, 439,544 patients (6.5%) had an SMI diagnosis. Although patients with schizophrenia and ONOP experienced higher crude rates of in-hospital mortality and stroke compared with those without SMI, only schizophrenic patients were at increased odds of mortality (OR, 1.10; 95% confidence interval [CI], 1.04-1.16), whereas ONOP was the only group at increased odds of stroke (OR, 1.53; 95% CI, 1.42-1.65) after multivariate adjustment. Patients with ONOP were the only group associated with increased odds of in-hospital bleeding compared with those without SMI (OR, 1.11; 95% CI, 1.04-1.17). All those with SMI subtypes were less likely to receive coronary angiography and percutaneous coronary intervention, with the schizophrenia group being at least odds of either procedure (OR, 0.46; 95% CI, 0.45-0.48 and OR, 0.57; 95% CI, 0.55-0.59, respectively).
Schizophrenia and ONOP are the only SMI subtypes associated with adverse clinical outcomes after AMI. However, all patients with SMI were less likely to receive invasive management for AMI, with female gender and schizophrenia diagnosis being the strongest predictors of conservative management. A multidisciplinary approach between psychiatrists and cardiologists could improve the outcomes of this high-risk population.
严重精神疾病(SMI)与心血管死亡率增加有关。我们试图研究伴有急性心肌梗死(AMI)的 SMI 患者的患病率、临床结局和管理策略。
纳入国家住院患者样本中的所有 AMI 住院患者,根据精神健康状况分为 5 组:无 SMI、精神分裂症、其他非器质性精神病(ONOP)、双相情感障碍和重度抑郁症。回归分析用于评估 SMI 亚型与临床结局之间的关联(所有结局的调整比值比 [OR],P≤0.001)。
在 2004 年至 2014 年期间,6968777 例 AMI 住院患者中有 439544 例(6.5%)有 SMI 诊断。尽管精神分裂症和 ONOP 患者的住院死亡率和卒中发生率高于无 SMI 患者,但只有精神分裂症患者的死亡率风险增加(OR,1.10;95%置信区间 [CI],1.04-1.16),而 ONOP 是唯一卒中风险增加的组(OR,1.53;95% CI,1.42-1.65),校正多变量后。与无 SMI 患者相比,ONOP 患者有更高的住院出血风险(OR,1.11;95% CI,1.04-1.17)。所有 SMI 亚型患者接受冠状动脉造影和经皮冠状动脉介入治疗的可能性较低,精神分裂症患者接受这两种治疗的可能性至少降低(OR,0.46;95% CI,0.45-0.48 和 OR,0.57;95% CI,0.55-0.59)。
精神分裂症和 ONOP 是 AMI 后唯一与不良临床结局相关的 SMI 亚型。然而,所有 SMI 患者接受 AMI 侵入性治疗的可能性较低,女性和精神分裂症诊断是保守治疗的最强预测因素。精神科医生和心脏病专家之间的多学科方法可以改善这一高危人群的结局。